Table 1

Baseline characteristics between CKDcohort and non-CKD cohort

non-CKD

N = 74098

CKD

N = 37049

n % n % P value*
Sex 1.00
Women 33948 45.8 16974 45.8
Men 40150 54.2 20075 54.2
Age group (years) 1.00
20–39 10710 14.5 5355 14.5
40–64 34742 46.9 17371 46.9
≥65 28646 38.7 14323 38.7
Mean (SD) (years) 57.5 (15.8) 58.3 (16.1) <0.0001
Co-morbidities
Hypertension 23702 32.0 21731 58.7 <0.0001*
Diabetes mellitus 6367 8.59 11517 31.1 <0.0001*
Ischemic heart disease 12896 17.4 12056 32.5 <0.0001*
Hyperlipidemia 7350 9.92 9762 26.4 <0.0001*
Tobacco use disorder 138 0.19 135 0.36 <0.0001*
Alcoholism 294 0.40 335 0.90 <0.0001*
Obesity 398 0.54 401 1.08 <0.0001*
Atrial fibrillation 638 0.86 740 2.00 <0.0001*
Parkinson's disease 790 1.07 680 1.84 <0.0001*
Cerebrovascular disease 8701 11.7 7876 21.3 <0.0001*
Major depressive disorder 852 1.15 652 1.76 <0.0001*
Elevated C-reactive protein -- -- --
Medication
Use of benzodiazepine 37902 51.2 25284 68.2 <0.0001*
Use of aspirin 6992 9.44 5822 15.7 <0.0001*
Use of other NSAIDs 63174 85.3 34698 93.7 <0.0001*
Use of COX2 14584 19.7 10901 29.4 <0.0001*

*Chi-square test comparing patients with and without CKD.

Cheng et al.

Cheng et al. BMC Nephrology 2012 13:129   doi:10.1186/1471-2369-13-129

Open Data